Microbot Medical Inc.

MBOT is the ticker symbol for Microbot Medical Inc., a publicly traded US company.

Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.

Key metrics include a return on equity of -5.0%, a debt-to-equity ratio of 0.05.

The company reports trailing twelve-month revenue of $32,762 and net loss of $3.67M.

FINOTAUR aggregates real-time and fundamental data on MBOT to help traders and investors make informed decisions. Track MBOT in your trading journal alongside other positions for a unified view of your portfolio.